The federal government although classifying cannabis as a schedule 1 substance giving it No medical benefit already has two patents on cannabinoids from as early as 1999 for its medical properties. U.S. Patent # 6,630,705: Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.
Posted on: Wed, 07 Jan 2015 19:18:28 +0000